The efficacy of intranasal leptin for opioid-induced respiratory depression depends on sex and obesity state is a research paper published in Frontiers in Physiology (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: K23 HL155730
NINDS NIH HHS
Grant: R01 NS112266
NHLBI NIH HHS
Grant: T32 HL110952
NHLBI NIH HHS
Grant: R61 HL156240
NHLBI NIH HHS
Grant: R01 HL128970
NIDA NIH HHS
Grant: R41 DA056239
National Institutes of Health
Grant: 5R01HL128970-02
Treatment of sleep apnea by targeting leptin signaling
National Institutes of Health
Grant: 5R01NS112266-04
Sleep fragmentation by brief awakenings as a surrogate to measure neuropathic spontaneous pain
National Institutes of Health
Grant: 4T32HL110952-04
Multi-Institutional Training in Genetic/Genomic Approaches to Sleep Disorders
National Institutes of Health
Grant: 1R41DA056239-01
Leptin Receptor Agonist as a Novel Prevention of Opioid Induced Respiratory Depression
National Institutes of Health
Grant: 7R61HL156240-02
Intranasal Leptin as A Novel Treatment of Opioid-Induced Respiratory Depression
Fields of Study
Keywords
Sustainable Development Goals